Skip to main content

Current Chapter

Current chapter – A list of each table and its purpose


Patient demographics tab (1)

Table 1 Patient demographics

This table shows the number of patients entered for your site (all pregnancies in date range) and their diabetes type.

Tables 2, 3 and 4

These tables show the number of patients separated by diabetes type and secondly by BMI and age. 


Pre-pregnancy planning (1) Tab (2)

Tables 5 – Use of folic acid prior to LMP all types

This table shows the use of folic acid prior to LMP (all pregnancies in date range). This table can be used to highlight the number of women in your audit sample that were taking folic acid prior to LMP. This can often be before the woman comes into contact your service, however it could be useful to see if any improvement can be made through better communication with primary care or by focusing on certain age groups. Any records where usage is not known highlight a data quality issue which could possibly be resolved by checking a patient’s records and updating the data base.

Table 6

This table shows the Use of folic acid prior to LMP (Dosage) This shows the number of patients from Table 5 where usage was known and highlights the dosage of folic acid used. Displayed percentages may not add to 100 because the denominator is ‘all’ pregnancies, not just those where dosage is known.

Tables 7, 8 and 9 – Use of Folic Acid prior to LMP by diabetes type

These tables show the dosage of those known to have taken folic acid (Table 5) separated by diabetes type. Displayed percentages may not add to 100 because the denominator is ‘all’ pregnancies, not just those where dosage is known.
 

Table 10 – First contact all types

This table shows the first contact the patient had with a health professional at 10 weeks or under. Where there are low numbers in this bracket it could highlight that improvement is required and local practice could be updated to facilitate these patients earlier (where possible) such as direct early access to the ante-natal team. Any pregnancies where first contact was later than 10 weeks, or where the first contact date has not been entered, are not listed but are included in the “total pregnancies”. Therefore percentages may not add to 100.

Tables 11, 12 and 13 – by diabetes type

These tables show the number of patients who were seen on or before 10 weeks (Table 10) separated by diabetes type.

Table 14 – HBA1c all types

This table shows the number of patients whose first HBA1c reading was taken before 12 weeks. The second line shows the patients that have just missed the 12week recommended guideline for first HBA1c taken in the first trimester, however in the annual report they would not be shown as an outlier. In the NPID annual report, we report on first trimester HBA1c, which is taken at less than 13 weeks, so this calculation is slightly different.

Tables 15, 16 and 17 – HBA1c by diabetes type

These tables show the HBA1c readings of those patients that were seen less than 12 weeks from table 14. Pregnancies where first HBA1c reading date less than 12 weeks but where no reading is recorded are included in the first row but not the break down.


Pre-pregnancy planning (2) Tab (3)

Table 18 – Diabetes treatment regime(s) at 1st day of LMP

This table can be used to highlight the diabetes treatment regimens or medications of the patients in your audit sample. Note that if a woman in your care is on more than one of the listed medications they will all be counted within the table. This means the number of medications listed may be more than your total number of completed entries.

Table 19 – ACE Inhibitors

This table shows patients who were recorded as taking ACE inhibitors or ARB at 1st Day of LMP

Table 20 - Statins

This table shows patients who were recorded as taking statins on 1st Day of LMP.


During pregnancy and outcomes tab (4)

Table 21 – Last HBA1c Reading all types

This table shows the number of patients whose last HBA1c reading was taken after 24 weeks of pregnancy as recommended. The second line shows the patients that have not had a reading taken at the greater than 24-week recommended guideline for HBA1c taken in the last trimester.

Tables 21, 22 and 23 – last HBA1c Reading by diabetes type

These tables show the women whose HBA1c was taken after 24 weeks split by diabetes type.

Table 24 – Pregnancy outcomes by diabetes types

This table shows pregnancy outcomes by diabetes types including live (birth), Still (birth), termination and miscarriage.

Table 25 – Congenital anomalies

This table shows the number of congenital anomalies in the live and still births listed in table 24.

Table 26 – Requiring neonatal care

This table shows the number of live births that required neonatal care.

These tables only include those patients that have a completed record in the Clinical Audit Platform (CAP).

A completed episode is classed as a record that includes the pregnancy end date within the data entered.


Last edited: 15 May 2025 10:43 am